Alps Dx today announced its official launch as an innovative diagnostics tooling and automation company focused on improving the speed, safety, and scalability of oral fluid drug testing and beyond.

Highest Grade Channel Sample Results to Date at Munro-Croesus Returns 124 g/t Au over 0.62 m within 39.5 g/t Au over 2.3 m From Newly Exposed Veins at the C Zone The results from the C Zone underscore ...

Billy Barr has braved the fourth season deep in the Rocky Mountains for more than 50 years, amassing tons of climate data.

The Ethiopian Neonatal Network (ENN) represents one of the first low-income country neonatal quality improvement (QI) ...

The global ESG reporting market is projected to grow at a healthy CAGR of approximately 15% through 2027. This growth is ...

The Teal Wand is an FDA-approved device for at-home cervical cancer screening. It works like a tampon, allowing women to ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Cell Counting ...

Schroeder, who is 28 and lives in Fargo, North Dakota, texts Cole “all day, every day” on OpenAI’s app. In the morning, he ...

VANCOUVER, BC / ACCESS Newswire / January 5, 2026 / Prince Silver Corp. (CSE:PRNC)(OTCQB:PRNCF)(Frankfurt:T130) (“Prince Silver”) or, the “Company, is pleased to provide a corporate update and outline ...

New federal guidance is expanding testing for cervical cancer with a self-collection method. Dr. Mara Gordon speaks to NPR about why this option might become popular for screening for HPV.

As laboratories strive to advance science, they must also confront an urgent reality: the environmental cost of research.

The HRSA screening guidelines now recommend use of either clinician-collected or patient-collected samples for human papillomavirus testing.